New Delhi: Drug firm on Monday reported a 45.03 per cent decline in its net profit to Rs 10.24 crore for the June ended quarter. The company had posted a net profit of Rs 18.63 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing.
Revenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago, it added.
The company’s board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2021-22, the filing said.
Shares of AstraZeneca Pharma India closed at Rs 3,364.45 per scrip on BSE, down 1.23 per cent from its previous close.
